T
Tivic Health Systems, Inc. (TIVC)
NCM – Real vaqt narxi. Valyuta: USD
0.93
-0.06 (-5.97%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.93
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 7:32 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NCM – Real vaqt narxi. Valyuta: USD
0.93
-0.06 (-5.97%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
0.93
0.00 (0.00%)
Bozordan keyin: Mar 27, 2026, 7:32 PM EDT
Tivic Health Systems, Inc. kechki bosqichdagi immunoterapiya kompaniyasi sifatida faoliyat yuritadi. Uning asosiy dori nomzodi Entolimod bo'lib, bu TLR5 agonisti bo'lib, o'tkir radiatsiya sindromini davolash uchun kechki bosqichda ishlab chiqilmoqda. Kompaniyaning portfelida, shuningdek, neytropeniya va limfotsitlarning charchashini davolash uchun Entolimod; va surunkali qo'llash uchun Entolimodning immunologik optimallashtirilgan varianti Entolasta mavjud. Bundan tashqari, u CDMO xizmatlarini taklif etadi. Kompaniya 2016-yilda tashkil etilgan va San Antonio, Texasda joylashgan.
| Ism | Lavozim |
|---|---|
| Ms. Lisa G. Wolf | CFO and Principal Financial & Principal Accounting Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-20 | 8-K | tivic_8k.htm |
| 2026-03-13 | 8-K | tivic_8k.htm |
| 2026-03-11 | 8-K | tivic_8k.htm |
| 2026-03-04 | 8-K | tivic_8k.htm |
| 2026-01-09 | DEF 14A | tivic_def14a.htm |
| 2025-12-29 | S-3 | tivicpreferred_s3.htm |
| 2025-12-11 | 8-K | tivic_8k.htm |
| 2025-11-18 | 8-K | tivc20251117_8k.htm |
| 2025-11-14 | 10-Q | tivc20250930_10q.htm |
| 2025-11-13 | 8-K | tivic_8k.htm |